Craig Whitehead, Biosimilars Global Regulatory Affairs Director, Pfizer
Craig Whitehead is currently Vice President, Biosimilars in Global Regulatory Affairs at Pfizer Inc., USA. Prior to this he had global responsibility for all CMC submissions of Biotech, Biologicals and Vaccines, for both development and commercial products. He has over 35 years of regulatory experience. He has worked for Eli Lilly, GSK and Pfizer. He has held global and regional regulatory roles covering US, EU and International markets and has extensive experience of working on both development and marketed products. Craig has a BSc in Chemistry (with Biochemistry and Management studies) from the University of London.